Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance

By Lemay A.   Dodin S.   Turcot L.   Déchêne F.   Forest J-C.  

Human Reproduction, Vol. 21, Iss. 1, 2006-01 ,pp. : 121-128

Oxford University Press

Access to resources Recommend Favorite

Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women with polycystic ovary syndrome: the effect of ethinyl estradiol-cyproterone acetate treatment

By Luboshitzky R.   Shen-Orr Z.   Herer P.   Nave R.  

Gynecological Endocrinology, Vol. 17, Iss. 6, 2003-12 ,pp. : 441-447

Informa Healthcare

Access to resources Recommend Favorite

Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome

By Wu Jie   Zhu Yiqing   Jiang Yunfei   Cao Yaoping  

Gynecological Endocrinology, Vol. 24, Iss. 7, 2008-01 ,pp. : 392-398

Informa Healthcare

Access to resources Recommend Favorite

The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case–control study

By Seaman H.E.   Vries C.S.de   Farmer R.D.T.  

Human Reproduction, Vol. 18, Iss. 3, 2003-03 ,pp. : 522-526

Oxford University Press

Access to resources Recommend Favorite

Effects of ethinyl estradiol-cyproterone acetate treatment on metabolic syndrome, fat distribution and carotid intima media thickness in polycystic ovary syndrome

By Karabulut Aysun   Demirlenk Semra   ŞŞevket Osman  

Gynecological Endocrinology, Vol. 28, Iss. 4, 2012-04 ,pp. : 245-248

Informa Healthcare

Access to resources Recommend Favorite